Canada markets closed

Sirona Biochem Corp. (SBM.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.06500.0000 (0.00%)
At close: 02:52PM EDT
Full screen
Previous Close0.0650
Open0.0700
Bid0.0600 x 0
Ask0.0650 x 0
Day's Range0.0650 - 0.0700
52 Week Range0.0650 - 0.2150
Volume22,000
Avg. Volume66,046
Market Cap16.514M
Beta (5Y Monthly)-0.31
PE Ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings DateJun 27, 2024 - Jul 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 27, 2006
1y Target EstN/A
  • GlobeNewswire

    Sirona Biochem Announces 2023 Annual Meeting Results

    VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 26,722,196, representing 10.52% of Sirona's issued and outstanding Common Shares. All matters put forward to shar

  • GlobeNewswire

    Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations

    VANCOUVER, British Columbia, March 13, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) announces a significant achievement in its quest to transform the skincare industry. Its subsidiary, TFChem, has successfully received formulations for its eagerly awaited GlycoProteMim™ based anti-aging serum from its formulation partner, Global Beauty Consulting (GBC). This marks a crucial step in Sirona Biochem's plan to offer innovative skincar

  • GlobeNewswire

    Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim™ in Early 2025

    VANCOUVER, British Columbia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF), also known as Sirona, is excited to share a new milestone in its journey. A recent exclusive video interview featuring Dr. Geraldine Deliencourt-Godefroy, Sirona's Chief Scientific Officer, has been released by the Investing News Network. In this interview, Dr. Deliencourt-Godefroy unveils Sirona's ambitious plans to introduce its innovative anti-aging product, GlycoProteM